Loading interface...

Lamifin Tablet

Manufactured byCanixa Life Sciences Pvt. Ltd.
ContainsTerbinafine
Description
Lamifin Tablet is an antifungal medicine. It is used to treat fungal infections like athlete's foot (itchy, scaly, and white patches between the toes), jock itch (red, itchy, and ring-shaped rashes in the groin, the area where the upper thigh meets the lowest part of the stomach), ringworm (red, itchy, and circular-shaped rashes with clear skin in the middle affecting the skin, scalp, or nails), and nail infections. This medicine works by killing the fungi by damaging its cell membrane (protective covering) and making it weaker. Thus, it prevents the spread of fungal infections. Lamifin Tablet shows side effects like nausea, vomiting, skin rash, headache, loss of appetite, etc. These side effects are usually mild and subside with time. If any of these side effects do not resolve with time or worsen, consult your doctor. Avoid taking this medicine if you are allergic to it. Lamifin Tablet can be taken with or without food. Your doctor will determine the dose and duration of treatment based on the severity of your condition. Complete the course of treatment even if you feel better after a few doses. If you stop taking this medicine early, the infection may reappear or worsen, which may be difficult to treat. Lamifin Tablet should be used with caution if you have liver or kidney problems. Your doctor may monitor your liver function regularly during treatment with this medicine. Inform your doctor if you notice the yellow colouring of your eyes or skin, dark urine, or stomach pain. Lamifin Tablet may interact with other medicines and cause undesired effects. Hence, inform your doctor if you are taking any other medicine. Consult your doctor if you are pregnant, or are breastfeeding.

Side effects

Major & minor side effects for Lamifin Tablet

  • Diarrhoea
  • Headache
  • Joint pain
  • Loss of appetite
  • Nausea or Vomiting
  • Dark urine
  • Yellowing of skin and eyes
  • Increase liver enzymes

Uses of Lamifin Tablet

What is it prescribed for?

  • Athlete's foot
  • Jock itch
  • Ringworm infection
  • Onychomycosis (fungal infection of the nails)
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time taken for Lamifin Tablet to show its action is not known.
  • How long do the effects of this medicine last?
    The time duration for which Lamifin Tablet remains effective in your body is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    Lamifin Tablet has no habit-forming tendency.
  • Can this medicine be taken during pregnancy?
    Lamifin Tablet is not recommended for use during pregnancy unless necessary. Hence, consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Lamifin Tablet is not recommended for use while breastfeeding as it passes into breastmilk. Hence, consult your doctor if you are breastfeeding.

Allergy

Avoid taking Lamifin Tablet if you are allergic to it. Seek immediate medical attention if you notice symptoms such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulty, etc.

Liver Disease

Lamifin Tablet is not recommended for use if you have liver problems. This medicine may cause further liver damage and worsen your condition.
Warnings for special population

Pregnancy

Lamifin Tablet is not recommended for use during pregnancy unless necessary. Hence, consult your doctor if you are pregnant.

Breast-feeding

Lamifin Tablet is not recommended for use while breastfeeding as it passes into breastmilk. Hence, consult your doctor if you are breastfeeding.
General warnings

Allergic skin reactions

Lamifin Tablet may cause serious skin reactions such as Stevens-Johnson syndrome (a serious skin condition that causes painful rashes and blisters that may start to peel), toxic epidermal necrolysis (a severe skin condition that causes blistering and peeling of the skin), etc. Consult your doctor if you experience a skin rash that persists or becomes worse.

Blood cell count

In rare cases, Lamifin Tablet may cause a decrease in the blood cell counts. Hence, this medicine should be used with caution if you have low blood cell counts. Your doctor may suggest regular blood tests to monitor your blood cell counts during treatment with this medicine. Your doctor may further recommend an alternative medicine based on your clinical condition.

Driving or operating machines

Avoid driving vehicles or operating machines if you feel dizzy during treatment with Lamifin Tablet.

Use in Children

Lamifin Tablet is not recommended for use in children below 18 years of age due to limited safety and efficacy data.

Missed Dose

Try not to skip the dose of Lamifin Tablet. In case you miss a dose, take it immediately. However, if the delay is more than 12 hours, skip the dose. Do not take a double dose to make up for the missed dose.

Overdose

Never take more than the prescribed dose. Seek emergency medical attention in case of an overdose with Lamifin Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Pimozide

Leflunomide

Codeine

Doxepin

Clozapine

Carvedilol

Duloxetine

Dextromethorphan

Disease interactions

Depression

Depression is a mental condition that causes a persistent feeling of sadness and loss of interest in daily activities. In some cases, Lamifin Tablet may cause depression. Hence, this medicine should be used with caution if you have depression. Contact your doctor immediately if you experience depressive symptoms.

Neutropenia

Neutropenia refers to low levels of neutrophils (a type of white blood cell that helps the body to fight infection) in your blood. Lamifin Tablet may cause neutropenia in some cases. Hence, this medicine should be used with caution if you have neutropenia. Your doctor may suggest regular blood tests to monitor the blood counts during treatment with this medicine.

Kidney Disease

Lamifin Tablet is filtered by the kidneys and removed from the body via urine. Hence, this medicine should be used with caution if you have kidney problems.
Food interactions
Information not available.
Lab interactions
Information not available.
Lamifin Tablet can be taken with or without food. Do not break, chew, or crush the tablet. Never take more or less than the prescribed dose. Do not skip any dose and complete the course of treatment even if you feel better after a few doses. Your doctor may monitor your liver functions and blood cell counts regularly during treatment with this medicine.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Effect on sleep is not established

How it works
Lamifin Tablet works by stopping the production of a chemical known as ergosterol, which is responsible for forming the fungal cell membrane (the protective covering of the fungi). Thus, it kills the fungi and stops the spread of infections.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Miscellaneous antifungals

Schedule

Schedule H

Pubchem.ncbi.nlm.nih.gov. 2021. Terbinafine. [online] Available at: [Accessed 25 February 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/1549008#section=Top

Medicines.org.uk. 2021. Terbinafine 250mg Tablet - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: [Accessed 21 October 2021].

https://www.medicines.org.uk/emc/product/7133#PRODUCTINFO

Mri.cts-mrp.eu. 2021. [online] Available at: [Accessed 21 October 2021].

https://mri.cts-mrp.eu/human/downloads/NL_H_0584_001_FinalPI_2of2.pdf

Accessdata.fda.gov. 2021. [online] Available at: [Accessed 21 October 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020539s021lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 20 Jan 2023

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.